The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism

NKH Yiew, BN Finck - American Journal of Physiology …, 2022 - journals.physiology.org
Pyruvate metabolism, a central nexus of carbon homeostasis, is an evolutionarily conserved
process and aberrant pyruvate metabolism is associated with and contributes to numerous …

The hepatic mitochondrial pyruvate carrier as a regulator of systemic metabolism and a therapeutic target for treating metabolic disease

KS McCommis, BN Finck - Biomolecules, 2023 - mdpi.com
Pyruvate sits at an important metabolic crossroads of intermediary metabolism. As a product
of glycolysis in the cytosol, it must be transported into the mitochondrial matrix for the energy …

Comparative study of dietary flavonoids with different structures as α-glucosidase inhibitors and insulin sensitizers

Y Jia, Y Ma, G Cheng, Y Zhang… - Journal of Agricultural and …, 2019 - ACS Publications
This work was designed to comparatively investigate 27 dietary flavonoids that act as α-
glucosidase inhibitors and insulin sensitizers. On the basis of the results of an in vitro …

Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice

WT Hodges, C Jarasvaraparn, D Ferguson… - Journal of Biological …, 2022 - ASBMB
The mitochondrial pyruvate carrier (MPC) is an inner mitochondrial membrane complex that
plays a critical role in intermediary metabolism. Inhibition of the MPC, especially in liver, may …

The role of peroxisome proliferator-activated receptor gamma and atherosclerosis: Post-translational modification and selective modulators

L Yin, L Wang, Z Shi, X Ji, L Liu - Frontiers in Physiology, 2022 - frontiersin.org
Atherosclerosis is the hallmark of cardiovascular disease (CVD) which is a leading cause of
death in type 2 diabetes patients, and glycemic control is not beneficial in reducing the …

[HTML][HTML] Treating hepatic steatosis and fibrosis by modulating mitochondrial pyruvate metabolism

KS McCommis, BN Finck - Cellular and molecular gastroenterology and …, 2019 - Elsevier
A hepatic comorbidity of metabolic syndrome, known as nonalcoholic fatty liver disease
(NAFLD), is increasing in prevalence in conjunction with the pandemics of obesity and …

The medicinal perspective of 2, 4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review

K Kajal, G Singh, T Pradhan, D Bhurta… - Archiv der …, 2022 - Wiley Online Library
Thiazolidinedione (2, 4‐TZD), commonly known as glitazone, is a ubiquitous heterocyclic
pharmacophore possessing a plethora of pharmacological activities and offering a vast …

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice

NKH Yiew, S Deja, D Ferguson, K Cho… - Iscience, 2023 - cell.com
The liver coordinates the systemic response to nutrient deprivation and availability by
producing glucose from gluconeogenesis during fasting and synthesizing lipids via de novo …

[HTML][HTML] Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction

L Oonthonpan, AJ Rauckhorst, LR Gray, AC Boutron… - JCI insight, 2019 - ncbi.nlm.nih.gov
The mitochondrial pyruvate carrier (MPC) occupies a central metabolic node by transporting
cytosolic pyruvate into the mitochondrial matrix and linking glycolysis with mitochondrial …

Mitochondrial pyruvate carrier function in health and disease across the lifespan

JL Buchanan, EB Taylor - Biomolecules, 2020 - mdpi.com
As a nodal mediator of pyruvate metabolism, the mitochondrial pyruvate carrier (MPC) plays
a pivotal role in many physiological and pathological processes across the human lifespan …